These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2108116

  • 1. Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils.
    Pruul H, McDonald PJ.
    J Antimicrob Chemother; 1990 Jan; 25(1):91-101. PubMed ID: 2108116
    [Abstract] [Full Text] [Related]

  • 2. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
    Minguez F, Ramos C, Barrientos S, Loscos A, Prieto J.
    Chemotherapy; 1991 Jan; 37(6):420-5. PubMed ID: 1760941
    [Abstract] [Full Text] [Related]

  • 3. In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram-negative pathogens.
    Debbia EA, Pesce A, Schito GC.
    Am J Med; 1992 Apr 06; 92(4A):45S-47S. PubMed ID: 1316070
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial and plasmid curing activity of lomefloxacin in vitro.
    Derlot E, Poyart-Salmeron C, Courvalin P.
    Eur J Clin Microbiol Infect Dis; 1989 Dec 06; 8(12):1048-52. PubMed ID: 2515963
    [Abstract] [Full Text] [Related]

  • 5. Intraphagocytic bioactivity of lomefloxacin against Pseudomonas aeruginosa.
    Cantón E, Jiménez T, Pemán J, Ramón MS, Gobernado M.
    J Antimicrob Chemother; 1993 Aug 06; 32(2):279-84. PubMed ID: 8226429
    [Abstract] [Full Text] [Related]

  • 6. Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens.
    Stratton CW, Weeks LS.
    Diagn Microbiol Infect Dis; 1989 Aug 06; 12(3 Suppl):29S-34S. PubMed ID: 2791495
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of action of lomefloxacin.
    Piddock LJ, Hall MC, Wise R.
    Antimicrob Agents Chemother; 1990 Jun 06; 34(6):1088-93. PubMed ID: 2168142
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis.
    DiVincenzo CA, Shatzer KL, Venezio FR.
    Diagn Microbiol Infect Dis; 1989 Jun 06; 12(3 Suppl):13S-16S. PubMed ID: 2507220
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of in vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacteriaceae, and Pseudomonas aeruginosa.
    Rossolini GM, Valentini S, Satta G.
    Diagn Microbiol Infect Dis; 1989 Jun 06; 12(3 Suppl):57S-64S. PubMed ID: 2507221
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial activity of lomefloxacin.
    Leigh DA, Tait S, Walsh B.
    J Antimicrob Chemother; 1991 May 06; 27(5):589-98. PubMed ID: 1885417
    [Abstract] [Full Text] [Related]

  • 11. In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinolone.
    Molinari G, Bandelloni R, Paglia P, Debbia E, Schito GC.
    Diagn Microbiol Infect Dis; 1989 May 06; 12(3 Suppl):53S-56S. PubMed ID: 2791499
    [Abstract] [Full Text] [Related]

  • 12. [In vitro evaluation of lomefloxacin].
    Dette GA, Knothe H.
    Arzneimittelforschung; 1989 Aug 06; 39(8):832-5. PubMed ID: 2818672
    [Abstract] [Full Text] [Related]

  • 13. Susceptibility pattern of bacterial isolates to lomefloxacin.
    Lalitha MK, Nisha AK, Bhattacharya SS, Ramamoorthy U, Lal HM.
    Indian J Med Res; 1990 May 06; 91():182-4. PubMed ID: 2397938
    [Abstract] [Full Text] [Related]

  • 14. Studies on the emergence of resistance to lomefloxacin in vitro.
    Kanematsu M, Greenwood D.
    Eur J Clin Microbiol Infect Dis; 1989 Aug 06; 8(8):741-5. PubMed ID: 2506046
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
    Fuentes F, Martín MM, Izquierdo J, Gomez-Lus ML, Prieto J.
    Chemotherapy; 1996 Aug 06; 42(5):354-62. PubMed ID: 8874975
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of lomefloxacin (NY-198 or SC 47111).
    Shah PM, Müller S, Kipp J, Stille W.
    Diagn Microbiol Infect Dis; 1989 Aug 06; 12(3 Suppl):97S-101S. PubMed ID: 2791506
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM, Lee GC, Ellis ME.
    Chemotherapy; 1991 Aug 06; 37(3):166-74. PubMed ID: 1889304
    [Abstract] [Full Text] [Related]

  • 18. In-vitro postantibiotic effect of sparfloxacin and ciprofloxacin against Pseudomonas aeruginosa and Enterococcus faecalis.
    Pastor A, Pemán J, Cantón E.
    J Antimicrob Chemother; 1994 Nov 06; 34(5):679-85. PubMed ID: 7706163
    [Abstract] [Full Text] [Related]

  • 19. Killing of gram-negative bacteria by ciprofloxacin within both healthy human neutrophils and neutrophils with inactivated O2-dependent bactericidal mechanisms.
    Cantón E, Peman J, Cabrera E, Velert M, Orero A, Pastor A, Gobernado M.
    Chemotherapy; 1999 Nov 06; 45(4):268-76. PubMed ID: 10394010
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of leucocyte killing of resistant bacteria selected during exposure to aminoglycosides or quinolones.
    Schlaeffer F, Blaser J, Laxon J, Zinner S.
    J Antimicrob Chemother; 1990 Jun 06; 25(6):941-8. PubMed ID: 2115038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.